🇺🇸 FDA
Patent

US 7951786

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

granted A61KA61K31/7088A61K38/00

Quick answer

US patent 7951786 (Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/7088, A61K38/00, A61K45/06, A61P